Restricted accessLetterFirst published online 2013-12
Reply to “Comments on Petrak et al.'s ‘Psychological Insulin Resistance in Type 2 Diabetes Patients Regarding Oral Antidiabetes Treatment,Subcutaneous Insulin Injections,or Inhaled Insulin’: Considerations for Language and Communication”
Holmes-TruscottE, SpeightJ: Comments on Petrak et al.'s “Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin”: considerations for language and communication. Diabetes Technol Ther, 2013; 15:1053–1054.
2.
PetrakF, HerpertzS, StriddeE, PfütznerA: Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin. Diabetes Technol Ther, 2013; 15:702–710.
3.
SpeightJ, ConnJ, DunningT, SkinnerTC; Diabetes Australia: Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes. Diabetes Res Clin Pract, 2012; 97:425–431.
4.
HunterP: Is political correctness damaging science? Peer pressure and mainstream thinking may discourage novelty and innovation. EMBO Rep, 2005; 6:405–407.
5.
PolonskyWH, HajosTR, DainMP, SnoekFJ: Are patients with type 2 diabetes reluctant to start insulin therapy? An examination of the scope and underpinnings of psychological insulin resistance in a large, international population. Curr Med Res Opin, 2011; 27:1169–1174.
6.
PetrakF, StriddeE, LeverkusF, CrispinAA, ForstT, PfütznerA: Development and validation of a new measure to evaluate psychological resistance to insulin treatment. Diabetes Care, 2007; 30:2199–2204.
